Standout Papers

The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in... 1998 2026 2007 2016 686
  1. The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children (1998)
    Robert B. Belshe, Paul M. Mendelman et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 16 from Science/Nature 81 standout
Sub-graph 1 of 19

Citing Papers

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
2022 StandoutScience
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
2021 StandoutScience
5 intermediate papers

Works of Ken Zangwill being referenced

Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine
2000
The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children
1998 Standout

Author Peers

Author Last Decade Papers Cites
Ken Zangwill 1415 171 355 433 8 1.6k
Karen Kotloff 1504 109 399 501 7 1.7k
Dominick Iacuzio 1272 91 251 418 10 1.4k
T. R. Cate 1479 129 506 557 47 2.0k
Alicia M. Siston 646 57 120 325 15 1.2k
Weigong Zhou 660 154 371 617 18 1.6k
Ellen Ypma 1449 1023 281 251 23 1.7k
Heinz‐Josef Schmitt 1160 343 161 533 37 1.6k
Micki Hultquist 855 41 356 292 13 1.2k
Jeanne‐Marie Devaster 1103 65 357 345 38 1.6k
Eliza Roy 1332 162 122 336 23 1.7k

All Works

Loading papers...

Rankless by CCL
2026